Postprandial Lipid Metabolism in Patients With Hypertriglyceridemia and Normo-lipidemic Controls: Medium Chain Fatty Acids (MCT) in Comparison to Long-chain, Saturated Fatty Acids (SFA) and Mono-unsaturated Fatty Acids (MUFA)
NCT ID: NCT03846908
Last Updated: 2021-09-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
13 participants
INTERVENTIONAL
2019-02-01
2021-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Monounsaturated Fatty Acids on Intestinal Lipid Metabolism in Insulin Resistant Subjects (MUFA )
NCT03872349
Postprandial Response After Intake of Meals With Different Fatty Acid Composition
NCT02729857
Comparison of the Effect of MCFA and LCFA on Postprandial Appetite and Lipemia
NCT05539742
The Effect of Fatty Acid Composition on Energy Intake and Satiety
NCT00242021
The Acute Effects of Interesterification of Commercially Used Fats on Postprandial Lipaemia and Satiety
NCT02365987
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MCT
subjects start with MCT fat load
MCT
patients will receive fat load with MCT
SFA
patients will receive fat load with SFA
MUFA
patients will receive fat load with MUFA
SFA
subjects start with SFA fat load
MCT
patients will receive fat load with MCT
SFA
patients will receive fat load with SFA
MUFA
patients will receive fat load with MUFA
MUFA
subjects start with MUFA fat load
MCT
patients will receive fat load with MCT
SFA
patients will receive fat load with SFA
MUFA
patients will receive fat load with MUFA
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MCT
patients will receive fat load with MCT
SFA
patients will receive fat load with SFA
MUFA
patients will receive fat load with MUFA
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* LDL-cholesterol \> 190 mg/dl
* Diabetes mellitus
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ludwig-Maximilians - University of Munich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Klaus Parhofer
Professor of Endocrinology and Metabolism
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Munich
Munich, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MCT-HTG
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.